However, several studies have reported an increase in tumor PD-L1 expression caused by cisplatin, leading to resistance against cisplatin-induced apoptosis and subsequent immune evasion (Tran et al., 2017; Grabosch et al., 2019; Hu et al., 2021). This evidence concerns the gene CD274 and neoplasm.